Fast recovery of haemodynamic and ventilatory functions after sugammadex bolus following rocuronium-induced anaphylactic shock refractory to conventional treatment;Récupération hémodynamique et ventilatoire rapide après injection de sugammadex lors d'un choc anaphylactique au rocuronium, réfractaire au traitement conventionnel

Annales Francaises d'Anesthesie et de Reanimation

Volumn 31, Issue 2, 2012, Pages 158-161

  Raft, J ^a   Leclercq, M ^a   Longrois, D ^b   Meistelman, C ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Anaphylaxis; Rocuronium; Sugammadex

Indexed keywords

ROCURONIUM; SUGAMMADEX;

ANAPHYLACTIC SHOCK; ARTICLE; BOLUS INJECTION; BRONCHOSPASM; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; CONVALESCENCE; DRUG INDUCED DISEASE; HEMODYNAMICS; HUMAN; HYPOTENSION; RESPIRATORY FUNCTION;

ANAPHYLAXIS; ANDROSTANOLS; FEMALE; GAMMA-CYCLODEXTRINS; HEMODYNAMICS; HUMANS; MIDDLE AGED; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PULMONARY VENTILATION; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 84856962452     PISSN: 07507658     EISSN: 17696623     Source Type: Journal    
DOI: 10.1016/j.annfar.2011.10.023     Document Type: Article

References (20)

1. Laxenaire M.C. épidémiologie des réactions anaphylactoïdes peranesthésiques. Quatrième enquête multicentrique (juillet 1994-décembre 1996). Ann Fr Anesth Reanim 1999, 18:796-809.
2. Mertes P.M., Karila C., Demoly P., Auroy Y., Ponvert C., Lucas M.M., et al. Quelle est la réalité du risque allergique en anesthésie? Méthodologie de surveillance des évènements rares. Classification. Incidence. Aspects cliniques (immédiats et retardés). Morbidité-mortalité. Substances responsables. Ann Fr Anesth Reanim 2011, 30:223-239.
3. Longrois D., Lejus C., Constant I., Bruyère M., Mertes P.M. Traitement des réactions anaphylactiques survenant en cours d'anesthésie et en particulier du choc anaphylactique. Ann Fr Anesth Reanim 2011, 30:312-322.
4. McDonnell N.J., Pavy T.J., Green L.K., Platt P.R. Sugammadex in the management of rocuronium-induced anaphylaxis. Br J Anaesth 2011, 106:199-201.
5. Funnell A.E., Griffiths J., Hodzovic I. A further case of rocuronium-induced anaphylaxis treated with sugammadex. Br J Anaesth 2011, 107:275-276.
6. Findsen L, Pedersen NA, Olsen SK. Should sugammadex be used for the treatment of anaphylaxia induced by rocuronium? (abstract) Annual Meeting ASA 2010.
7. Debaene B., Meistelman C. Indications et utilisation clinique du sugammadex. Ann Fr Anesth Reanim 2009, 28(Suppl. 2):57-63.
8. Sparr H.J., Vermeyen K.M., Beaufort A.M., Rietbergen H., Proost J.H., Saldien V., et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology 2007, 106:935-943.
9. Le Corre F., Nejmeddine S., Fatahine C., Tayar C., Marty J., Plaud B. Recurarization after sugammadex reversal in an obese patient. Can J Anaesth 2011, 58:944-947.
10. Jones P.M., Turkstra T.P. Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown. Anaesthesia 2010, 65:89-90.
11. Wordsworth H.I., Raja Y., Harrison S. Sugammadex and rocuronium-induced anaphylaxis. Br J Anaesth 2011, 106:911-912.
12. Rocq N., Favier J.C., Plancade D., Steiner T., Mertes P.M. Successful use of terlipressin in post-cardiac arrest resuscitation after an epinephrine-resistant anaphylactic shock to suxamethonium. Anesthesiology 2007, 107:166-167.
13. Baldo B.A., McDonnell N.J., Pham N.H. Drug-specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy. Clin Exp Allergy 2011, 7:1-16.
14. Magnan A., Pipet A., Bérard F., Malinovsky J.M., Mertes P.M. Mécanismes immunologiques de l'allergie peranesthésique. Ann Fr Anesth Reanim 2011, 30:240-245.
15. Birnbaum J., Vervloet D. Mechanisms of anaphylactic reactions to muscle relaxants: role of allergenic determinants. Monogr Allergy 1992, 30:15-23.
16. Didier A., Cador D., Bongrand P., Furstoss R., Fourneron P., Senft M., et al. Role of the quaternary ammonium ion determinants in allergy to muscle relaxants. J Allergy Clin Immunol 1987, 79:578-584.
17. Gijsenbergh F., Ramael S., Houwing N., van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005, 103:695-703.
18. Bom A., Bradley M., Cameron K., Clark J.K., Van Egmond J., Feilden H., et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002, 41:266-270.
19. Leysen J., Bridts C.H., De Clerck L.S., Ebo D.G. Rocuronium-induced anaphylaxis is probably not mitigated by sugammadex: evidence from an in vitro experiment. Anaesthesia 2011, 66:526-527.
20. http://www.sfar.org/article/693/sugammadex-in-the-management-of-rocuronium-induced-anaphylaxis.